336 related articles for article (PubMed ID: 26247350)
1. Bayesian methods for the design and analysis of noninferiority trials.
Gamalo-Siebers M; Gao A; Lakshminarayanan M; Liu G; Natanegara F; Railkar R; Schmidli H; Song G
J Biopharm Stat; 2016; 26(5):823-41. PubMed ID: 26247350
[TBL] [Abstract][Full Text] [Related]
2. Bayesian approach to noninferiority trials for proportions.
Gamalo MA; Wu R; Tiwari RC
J Biopharm Stat; 2011 Sep; 21(5):902-19. PubMed ID: 21830922
[TBL] [Abstract][Full Text] [Related]
3. Bayesian approach for assessing noninferiority in a three-arm trial with binary endpoint.
Ghosh S; Tiwari RC; Ghosh S
Pharm Stat; 2018 Jul; 17(4):342-357. PubMed ID: 29473291
[TBL] [Abstract][Full Text] [Related]
4. The network meta-analytic-predictive approach to non-inferiority trials.
Schmidli H; Wandel S; Neuenschwander B
Stat Methods Med Res; 2013 Apr; 22(2):219-40. PubMed ID: 22218367
[TBL] [Abstract][Full Text] [Related]
5. Evidence synthesis from aggregate recurrent event data for clinical trial design and analysis.
Holzhauer B; Wang C; Schmidli H
Stat Med; 2018 Mar; 37(6):867-882. PubMed ID: 29152777
[TBL] [Abstract][Full Text] [Related]
6. Approaches for testing noninferiority in two-arm trials for risk ratio and odds ratio.
Chowdhury S; Tiwari RC; Ghosh S
J Biopharm Stat; 2019; 29(3):425-445. PubMed ID: 30744476
[TBL] [Abstract][Full Text] [Related]
7. New approaches for testing non-inferiority for three-arm trials with Poisson distributed outcomes.
Ghosh S; Paul E; Chowdhury S; Tiwari RC
Biostatistics; 2022 Jan; 23(1):136-156. PubMed ID: 32385495
[TBL] [Abstract][Full Text] [Related]
8. Issues with statistical risks for testing methods in noninferiority trial without a placebo ARM.
Hung HM; Wang SJ; O'Neill R
J Biopharm Stat; 2007; 17(2):201-13. PubMed ID: 17365218
[TBL] [Abstract][Full Text] [Related]
9. Bayesian approach to the design and analysis of non-inferiority trials for anti-infective products.
Gamalo MA; Tiwari RC; LaVange LM
Pharm Stat; 2014; 13(1):25-40. PubMed ID: 23913880
[TBL] [Abstract][Full Text] [Related]
10. Bayesian randomized clinical trials: From fixed to adaptive design.
Yin G; Lam CK; Shi H
Contemp Clin Trials; 2017 Aug; 59():77-86. PubMed ID: 28455232
[TBL] [Abstract][Full Text] [Related]
11. Robust meta-analytic-predictive priors in clinical trials with historical control information.
Schmidli H; Gsteiger S; Roychoudhury S; O'Hagan A; Spiegelhalter D; Neuenschwander B
Biometrics; 2014 Dec; 70(4):1023-32. PubMed ID: 25355546
[TBL] [Abstract][Full Text] [Related]
12. Likelihood ratio and a Bayesian approach were superior to standard noninferiority analysis when the noninferiority margin varied with the control event rate.
Kim MY; Xue X
J Clin Epidemiol; 2004 Dec; 57(12):1253-61. PubMed ID: 15617951
[TBL] [Abstract][Full Text] [Related]
13. Bayesian noninferiority test for 2 binomial probabilities as the extension of Fisher exact test.
Doi M; Takahashi F; Kawasaki Y
Stat Med; 2017 Dec; 36(30):4789-4803. PubMed ID: 28960376
[TBL] [Abstract][Full Text] [Related]
14. Non-inferiority trials: design concepts and issues - the encounters of academic consultants in statistics.
D'Agostino RB; Massaro JM; Sullivan LM
Stat Med; 2003 Jan; 22(2):169-86. PubMed ID: 12520555
[TBL] [Abstract][Full Text] [Related]
15. A case for Bayesianism in clinical trials.
Berry DA
Stat Med; 1993 Aug; 12(15-16):1377-93; discussion 1395-404. PubMed ID: 8248653
[TBL] [Abstract][Full Text] [Related]
16. Randomization as a basis for inference in noninferiority trials.
Wiens BL
Pharm Stat; 2006; 5(4):265-71. PubMed ID: 17128425
[TBL] [Abstract][Full Text] [Related]
17. Bayesian approaches in medical device clinical trials: a discussion with examples in the regulatory setting.
Bonangelino P; Irony T; Liang S; Li X; Mukhi V; Ruan S; Xu Y; Yang X; Wang C
J Biopharm Stat; 2011 Sep; 21(5):938-53. PubMed ID: 21830924
[TBL] [Abstract][Full Text] [Related]
18. Making sense of noninferiority: a clinical and statistical perspective on its application to cardiovascular clinical trials.
Kaul S; Diamond GA
Prog Cardiovasc Dis; 2007; 49(4):284-99. PubMed ID: 17185116
[TBL] [Abstract][Full Text] [Related]
19. A Bayesian meta-analytic approach for safety signal detection in randomized clinical trials.
Odani M; Fukimbara S; Sato T
Clin Trials; 2017 Apr; 14(2):192-200. PubMed ID: 28059578
[TBL] [Abstract][Full Text] [Related]
20. A dynamic power prior for borrowing historical data in noninferiority trials with binary endpoint.
Liu GF
Pharm Stat; 2018 Feb; 17(1):61-73. PubMed ID: 29125220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
